NYSE: CLB · Energy & Transportation · 2 alerts · CIK 1958086
Share price
$8.45Close, Nov 16
Market cap
$387M
Shares outstanding
45.82MLatest SEC cover page
Sector
Energy & Transportation
Industry
Oil & Gas Field Services, NECSIC 1389
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Core Laboratories Inc. filings on SEC EDGAR ↗
Core Laboratories Inc. reported total revenue of $132.1 million for the third quarter of 2026, a slight decrease from $134.5 million in the prior year period. Net income attributable to the company fell to $5.4 million ($0.12 per diluted share) compared to $14.2 million ($0.30 per diluted share) in 2025, primarily driven by lower operating income and higher interest expenses.
Core Laboratories reported Q3 2026 revenue of $132.1 million, up 6% sequentially, driven by international demand for laboratory services and strong U.S. product sales. The company achieved GAAP EPS of $0.12 and announced a quarterly cash dividend of $0.01 per share. Management noted improving demand across international regions, particularly in the Middle East and Asia-Pacific, despite ongoing geopolitical headwinds.
Term
Q3 2026
“Our third quarter results delivered sequential revenue growth across both of our operating segments. International revenue was up in Europe-Africa, Asia-Pacific, Latin America, and the Middle East. There was a gradual improvement in activity in the Middle East, particularly late in the quarter.”
Larry Bruno, CEO
“Looking at the mid to long term, we see our key international regions positioned for growth, including long-cycle offshore exploration and appraisal projects. Face-to-face meetings with clients throughout Asia-Pacific during the third quarter reinforced our view that the region is entering a period of sustained activity growth, with projects advancing across both conventional and unconventional plays.”